Colchicine Pill clinical trials
Colchicine Pill is named as an intervention in 3 current clinical trials in our China and France registers. 2 are recruiting patients now. The most common phase is Not applicable. The sponsor with the most trials is Beijing Anzhen Hospital (2). The most-studied condition is CAD - Coronary Artery Disease.
Patient leaflets for Colchicine Pill
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Trials by status
Trials by phase
Clinical trials of Colchicine Pill
3 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Colchicine Versus Placebo in Acute Myocarditis Patients
NCT05855746 · ClinicalTrials.gov ↗ · Acute Myocarditis
|
Phase 3 | Recruiting | Assistance Publique - Hôpitaux de Paris | France |
|
Treatment of ACuTe Coronary Syndromes With Low-dose colchICine
NCT06215989 · ClinicalTrials.gov ↗ · Acute Coronary Syndrome, Unstable Angina, ST Elevation Myocardial Infarction
|
Not applicable | Recruiting | Beijing Anzhen Hospital | China |
|
Low-dose Colchicine for CABG Graft Failure Prevention
NCT07569328 · ClinicalTrials.gov ↗ · CAD - Coronary Artery Disease, CABG, Colchicine
|
Not applicable | Not yet open | Beijing Anzhen Hospital | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with Colchicine Pill
8 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Beijing Anzhen Hospital | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
By country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 2 | 1 |
| Clinical trials in France | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about Colchicine Pill trials
How many clinical trials are testing Colchicine Pill?
3 current trials in our China and France registers name Colchicine Pill as a drug or biological intervention, as of the registry sync on 11 November 2026. Completed and withdrawn studies are not counted.
Are Colchicine Pill trials recruiting patients?
Yes. 2 of the 3 trials are recruiting: 1 with sites in China and 1 with sites in France. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Colchicine Pill clinical trials?
Beijing Anzhen Hospital (2) and Assistance Publique - Hôpitaux de Paris (1). The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Colchicine Pill works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Colchicine Pill works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Colchicine Pill (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 11 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.